retatrutide phase 2 nejm 2023 obesity trial jastreboff Number 1 Top Cardiometabolic Story of 2023: with #retatrutide, a GIP-GLP-1-GCG receptor triple agonist, resulted in a mean weight reduction of 24.2% after 48 weeks. https://t.co/aED6xEFDI3 is oral or injection Health Topics Package Size:3-month supply

retatrutide phase 2 nejm 2023 obesity trial jastreboff Number 1 Top Cardiometabolic Story of 2023: with #retatrutide, a GIP-GLP-1-GCG receptor triple agonist, resulted in a mean weight reduction of 24.2% after 48 weeks. https://t.co/aED6xEFDI3 is oral or injection Health Topics Package Size:3-month supply

is oral or injection semaglutide better GLP-1 Drops Vs Injection, Pros, Cons, And Reality Explained Oral Semaglutide vs. Injectable: Which –

Together, these advancements in nanocarrier design demonstrate the versatility and clinical potential of polymer- and protein-based delivery systems for GLP-1RAs

Health Topics

Package Size:3-month supply

While research exploring GLP-1 misuse and eating disorder relapse is still limited, experts say they’re seeing a growing number of cases firsthand